Roche Holding AG
http://www.roche.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Roche Holding AG
Alentis Aims To Put The Brakes On Fibrosis
Building on 20 years of work and positive preclinical data, and backed by a fresh injection of cash, Alentis is taking its liver fibrosis candidate into Phase I trials in the fourth quarter.
GSK Spends Heavily On iTeos' TIGIT To Build A New IO Cornerstone
GSK will pay iTeos $625m up front to codevelop and cocommercialize EOS-448, now in Phase I development for advanced solid tumors.
ASCO Data Position Contenders In Battle Of The SERDs
With at least two potential candidates being touted as potential best-in-class by their sponsors, the oral SERD market is shaping up to be highly competitive. Sanofi has taken an early lead in expanding the scope of its Phase III breast cancer program.
Roche’s Novel Ranibizumab Implant Among Myriad New Filings In EU
The European Medicines Agency has added 13 new drugs to its list of products that are under review for potential pan-EU marketing approval.
Company Information
- Industry
- In Vitro Diagnostics
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Adheron Therapeutics
- Anadys Pharmaceuticals, Inc.
- Ariosa Diagnostics
- Arius Research, Inc.
- Boehringer Mannheim
- CAPP Medical
- Chugai Pharmaceutical Co., Ltd.
- Dutalys GmbH
- Flatiron Health
- Foundation Medicine
- Genentech Inc.
- GeneWEAVE BioSciences, Inc.
- Genia Technologies, Inc.
- GlycArt Biotechnology
- Hoffmann-La Roche
- Inflazome Ltd.
- Ignyta, Inc. (RXDX) (Actagene Oncology, Inc
- NexDx, Inc.)
- Inception 5
- InterMune, Inc.
- Inflazome Ltd.
- IQuum, Inc.
- Jecure Therapeutics
- Kapa Biosystems, Inc.
- Marcadia Biotech, Inc.
- Medingo Ltd.
- Memory Pharmaceuticals Corporation
- mtm laboratories AG
- Piramed Pharma
- Santaris Pharma A/S
- Seragon Pharmaceuticals
- Signature Diagnostics AG
- Stratos Genomics
- Syntex Corporation
- Tanox, Inc.
- Tensha Therapeutics, Trophos SA
- Ventana Medical Systems, Inc.
- Viewics, Inc.